Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05925933
Other study ID # DFI/DST/2023
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date October 1, 2023
Est. completion date October 31, 2026

Study information

Verified date June 2023
Source Diabetes Foundation, India
Contact Anoop Misra, MD
Phone 01149101222
Email anoopmisra@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Diabetes/ prediabetes is a substantial problem in India not only because it itself can be associated with morbidities such as coronary artery disease but also because it is a point of importance for the prevention of other diseases. It is not clear if a high protein calorie diet in the Indian population associated with a heightened tendency for prediabetes, metabolic syndrome, atherosclerosis and dysmetabolic state etc. could, besides lifestyle factors, be related to diet, or interaction between the two. The analysis of whole blood transcriptomes and plasma metabolomics profiles may be a potentially useful tool for the assessment of metabolic health status. The proposed study is the first to perform a detailed gene expression profiling with the use of next-generation sequencing technology to assess the differences in molecular mechanisms in the peripheral blood of subjects with prediabetes.


Description:

This study will be conducted at the outpatient department of the National Diabetes, Obesity and Cholesterol Foundation (N-DOC), Diabetes Foundation (India) (DFI)and Fortis-C-DOC, Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology, New Delhi, India. Experimental Protocol: In this study, a total of 60 subjects with pre-diabetes and 60 age and body mass index, and gender-matched controls (age 18-40 years) will be recruited. They will be randomized to an equicaloric normal diet (carbohydrates 60%, protein 15%, and fat 25%) or a high protein diet (carbohydrates 45%, protein 29%, and fat 26%) over 8-week periods. All assessments as done on day 1 will be repeated at day 60.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date October 31, 2026
Est. primary completion date September 30, 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 50 Years
Eligibility Exclusion Criteria: - Acute infections and advanced end-organ damage. - History of hepatitis or pancreatitis, abnormal liver and renal function tests. - Recent (<3 months) changes in weight (=5%) and/or weight changing medications. - Subjects with metallic implants, pacemaker leads, radioactive seeds or surgical staples in the body. Inclusion Criteria Cases: - Age 18 to 50 years. Subjects with pre-diabetes on oral glucose tolerance test (OGTT) - Fasting blood glucose=100mg/dl and <126 mg/dl or 2-h plasma glucose =140mg/dl and <200mg/dl (after ingestion of 75 grams of anhydrous oral glucose) or both. Controls: - Age 18 to 50 years. Normoglycemia by OGTT - Fasting blood glucose <100mg/dl and 2-h plasma glucose <140mg/dl (after ingestion of 75 gram of anhydrous oral glucose).

Study Design


Intervention

Other:
Intervention
high protein diet (carbohydrates 45%, protein 29%, and fat 26%) over 8-week periods.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Diabetes Foundation, India

Outcome

Type Measure Description Time frame Safety issue
Primary Body Mass Index BMI will be calculated by using formula weight (Kg)/height (m2). 6 Months
Primary Body Fat Body estimations will be done by DEXA Scan 2 MONTHS
Primary Liver Fat Liver fat will be done by MRI Scan 2 Months
Primary Next Generation sequencing 06 MONTHS
Primary Pancreatic fat Pancreatic fat estimation will be done by MRI 06 MONTHS
Primary RNA Extraction 06 MONTHS
Primary Metabolomics profile 06 MONTHS
See also
  Status Clinical Trial Phase
Completed NCT04082585 - Total Health Improvement Program Research Project
Enrolling by invitation NCT05367024 - Broccoli Effect on Glycated Haemoglobin (HbA1c) N/A
Withdrawn NCT02400450 - Designer Functional Foods on Parameters of Metabolic and Vascular in Prediabetes N/A
Completed NCT02933424 - Project Plant Protein: the P3 Study in Humans N/A
Completed NCT02656212 - Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin (Part 2) Phase 1
Completed NCT02330276 - Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin Phase 1
Completed NCT01488279 - Effect of Sitagliptin on Short-Term Metabolic Dysregulation of Oral Glucocorticoid Therapy N/A
Completed NCT00831129 - A Study for Pre-diabetic Patients With Cholesterol Lowering Drugs Phase 2/Phase 3
Completed NCT00536250 - Study to Investigate the Pathophysiology of Type 2 Diabetes in Youth N/A
Recruiting NCT05563090 - Investigating the Syndrome Differentiation of Diabetic and Pre-diabetic Using Digitalized TCM Diagnostic Tools
Active, not recruiting NCT04991142 - Models of Nutrition From Continuous Glucose Monitors
Completed NCT02759055 - Pre-Diabetes Cardiovascular (CV) Care (Pre-Diabetes Wizard) N/A
Completed NCT00775684 - Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass N/A
Completed NCT03695913 - Continuous Glucose Monitoring (CGM) With a Low Carbohydrate Diet to Reduce Weight in Patients With Pre-Diabetes N/A
Completed NCT04051008 - CTSI Pilot: Improving Adherence to Diabetic Diet N/A
Recruiting NCT04897945 - A Shared Decision Making Intervention for Diabetes Prevention in Women With a History of Gestational Diabetes Mellitus N/A
Not yet recruiting NCT04442451 - Mechanisms of Fatigability With Diabetes N/A
Active, not recruiting NCT05654051 - The SLIM LIVER Study Phase 2
Completed NCT02919397 - Motivational Instant Messaging and E-diabetes Prevention Programme for High Risk of Type 2 Diabetes N/A
Completed NCT00589459 - Gender Differences in Prevalence of Undiagnosed Diabetes in ACS